Praxis Dr. Jörg Winkler Pneumologisches Studienzentrum
- Address
- Goldschmidtstrasse 30, 04103 Leipzig, Germany
Praxis Dr. Jörg Winkler Pneumologisches Studienzentrum
This specialized pneumology research center focuses on advancing treatment options for respiratory allergic conditions through rigorous clinical investigation. The center conducts sophisticated immunotherapy trials aimed at improving outcomes for patients suffering from allergen-induced respiratory disorders.
- Subcutaneous immunotherapy (SCIT) for pollen-induced allergic rhinitis and rhinoconjunctivitis
- House dust mite (HDM) allergy treatment and management
- Respiratory allergic conditions with or without asthma complications
The research center specializes in evaluating novel allergoid formulations and standardized allergen extracts through placebo-controlled studies. Their expertise encompasses both seasonal allergens, such as birch pollen, and perennial triggers like house dust mites, assessing treatment efficacy using validated scoring systems including the Total Combined Rhinitis Score (TCRS). This comprehensive approach enables the center to contribute valuable data on immunotherapy protocols for adolescent and adult populations with moderate to severe allergic respiratory conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 42 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 42 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Inmunotek S.L.3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Praxis Dr. Jörg Winkler Pneumologisches Studienzentrum
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled Study of Subcutaneous Mannan-Conjugated Betula Pendula Pollen Allergoid in Birch Pollen-Induced Allergic Rhinitis | CCDRD Cooperative Clinical Drug Research and Development AG, ClinCompetence Cologne GmbH, Inmunotek S.L. | Phase III | Not Recruiting | Feb 2024 | Jun 2024 |
IMP list
lock Showing 1 of 42 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Budesonide | 3 | Unknown | 2021-04-25 | 2026-06-01 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.